Crinetics Pharmaceuticals Inc
CRNXToday
0.00%
5 Days
-0.01%
1 Month
+0.94%
6 Months
+94.96%
Year to Date
+81.93%
1 Year
+188.06%
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled
• Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for ten billion dollars cash. • The acquisition includes a premium exceeding one hundred percent of Crinetics' share price. • Executives sold company shares under pre-arranged trading plans during record-high valuations.
Gilead Sciences Inc Stock (GILD) Closed Up by 5.35% on Jul 7: What Signal Does It Send?
• Gilead shares rose following successful Phase 3 HIV trial results. • European regulators approved Trodelvy for first-line cancer monotherapy. • HSBC upgraded Gilead stock to buy, citing an undervalued pipeline.
Johnson & Johnson Stock (JNJ) Moved Up by 3.71% on Jul 7: What Signal Does It Send?
• Positive MEMBRANE clinical trial results boosted market sentiment for Johnson & Johnson shares. • MedTech division growth and sector-wide capital rotation support the company's recent share gains. • Analysts maintain a Buy rating with an average price target of $254.63.
Eli Lilly and Co Stock (LLY) Moved Up by 3.08% on Jul 7: Facts Behind the Movement
• JPMorgan increased its Eli Lilly price target citing strong revenue and pipeline growth. • The new Medicare GLP-1 Bridge program expands insurance coverage and boosts patient access. • Analysts expect the company's upcoming earnings to exceed current market consensus estimates.
Crinetics Pharmaceuticals Inc's Score
Media Coverage
Analyst Rating
Crinetics Pharmaceuticals Inc Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Crinetics Pharmaceuticals Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 12.06% |
| Wellington Management Company, LLP | 7.62% |
| BlackRock Institutional Trust Company, N.A. | 6.58% |
| Farallon Capital Management, L.L.C. | 6.58% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.95% |
| Investment Advisor/Hedge Fund | 40.84% |
| Hedge Fund | 14.42% |
| Venture Capital | 1.76% |
Related Instruments
Popular Instruments
